Business

Result of Placing

Result of Placing.

articleOxford Biomedica PlcMarch 9, 20183/company/oxford-biomedica-plc/news/result-of-placing-159
Result of Placing

About this update from Oxford Biomedica Plc

[{"type":"text","content":"\n \nRNS Number : 3338H Oxford Biomedica PLC 09 March 2018  \n\n9 March 2018\nNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL.\nTHIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER TO BUY, ACQUIRE OR SUBSCRIBE FOR (OR THE SOLICITATION OF AN OFFER TO BUY, ACQUIRE OR SUBSCRIBE FOR) ORDINARY SHARES TO ANY PERSON WITH A REGISTERED ADDRESS IN, LOCATED IN, OR WHO IS A RESIDENT OF, THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL OR CONTRAVENE ANY REGISTRATION OR QUALIFICATION REQUIREMENTS UNDER THE SECURITIES LAWS OF ANY SUCH JURISDICTION.\nOXFORD BIOMEDICA PLC \nRESULT OF PLACING TO RAISE £20.5 MILLION\nOxford, UK - 9 March 2018: Oxford BioMedica plc (\"Oxford BioMedica\" or \"the Company\"; LSE: OXB), a leading gene and cell therapy company, is pleased to announce the successful completion of the placing announced earlier today (the \"Placing\").\nA total of 174,346,817 new ordinary shares of one pence each in the capital of the Company (the \"Placing Shares\") have been conditionally placed by Peel Hunt LLP (\"Peel Hunt\") and WG Partners LLP (\"WG\") (together, the \"Joint Bookrunners\") with new and existing investors at a price of 11.75 pence per Placing Share (the \"Placing Price\") raising gross proceeds of £20.5 million for the Company and approximately £19.3 million net of expenses. The Placing Shares represent 5.3 per cent. of the issued ordinary share capital of the Company prior to the Placing. The Placing Price represents a discount of 5.85 per cent. to the closing price of 12.48 pence on 8 March 2018  and a 5.70 per cent. discount to the middle market price of 12.46 pence on the London Stock Exchange at the time of announcement of the Placing.\nThe Placing has been supported by a range of new and existing institutional shareholders from both the U.S. and the UK.\nThe Placing Shares will, when issued, be credited as fully paid and will be issued subject to the Company's articles of association and will rank pari passu in all respects with the existing issued ordinary shares...

More updates from Oxford Biomedica Plc